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Has the revision rate changed for 36 mm metal-on-metal total hip replacements with 
Pinnacle cups by year of implantation? An interrupted time-series analysis using data 
from the National Joint Registry for England and Wales 
 
Abstract 
 
Aims 
To determine whether revision rates for metal-on-metal total hip replacements (MoM THRs) 
with Pinnacle cups varied by year of implantation, and compare these to revision rates for 
other MoM THR designs. 
 
Methods 
Data from the National Joint Registry included 36mm MoM THRs with Pinnacle cups 
implanted between 2003-2012 with at least 5-years follow-up (n=10,776), and a control 
group of other MoM THRs (n=13,817). The effect of implantation year on all-cause revision 
rates was assessed using Cox regression and interrupted time-series analysis. 
 
Results 
For Pinnacles, compared with hips implanted in 2004-2006, hips implanted in 2007-2012 had 
higher revision rates (hazard ratio (HR)=2.01; CI=1.57-2.57; p<0.001). For primaries 
performed after 2007, the number of revisions per 1000 implant-years at-risk significantly 
increased by 5.20 (CI=0.52-9.89; p=0.033) compared with pre-2007. In the control group, 
hips implanted in 2007-2012 also had higher revision rates (HR=1.77; CI=1.49-2.10; 
p<0.001), with revisions per 1000 implant-years for primaries performed after 2007 
significantly increasing by 6.13 (CI=1.42-10.83; p=0.016). 
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Conclusion 
Five-year revision rates were significantly increased in all primary MoM THRs implanted 
from 2007 onwards. Contrary to recent reports the finding was not specific to Pinnacles, and 
may be explained by increased surveillance and lowering of the revision threshold over time. 
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Introduction 
Metal-on-metal total hip replacements (MoM THRs) are associated with high failure rates 
due to the release of cobalt and chromium from the bearing surface and/or the femoral head-
stem taper junction.1-6 There is now evidence to suggest that similar problems can also occur 
in patients without MoM bearing surfaces.7 Worldwide authorities recommend MoM THR 
patients undergo regular surveillance to detect complications early.8-10 The Pinnacle system 
(DePuy, Leeds, United Kingdom) represents one of the most commonly used MoM THR 
devices with approximately 180,000 implanted worldwide.3, 11-13 High revision rates have 
been reported for MoM THRs with Pinnacle cups (subsequently referred to as Pinnacles) in 
registries3, 11 and large single-centre studies.12, 14-17 
 
Two recent studies together involving over 1,000 primary 36 mm Pinnacles (8.4% of all such 
implants within the National Joint Registry (NJR)) both reported that hips implanted from 
2006 onwards had a significantly increased risk of failure compared with those implanted 
before 2006.12, 17 Explant analysis also demonstrated that Pinnacles manufactured from 2006 
onwards were increasingly likely to have lower clearance values than intended by the 
manufacturer.12 It has been postulated that these previously unrecognised changes in the 
device manufacturing process may be responsible for the increased failure rates reported 
from 2006 onwards.12, 17 
 
These observations are concerning and, if specific to Pinnacle cups, may require important 
changes to surveillance for Pinnacle patients.8-10 Assessment of the effect of year of Pinnacle 
implantation on revision rates in a large unselected population would therefore be advisable. 
Although an initial review of Pinnacles recorded in the NJR did not show a higher revision 
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rate for the batch numbers identified previously12 compared to the others, it was suggested 
that this analysis would be repeated.18 
 
This study aimed to validate the findings from the two recent Pinnacle cohorts using the NJR 
dataset and novel statistical methodology.12, 17 We investigated whether five-year revision 
rates for 36 mm MoM THRs with Pinnacle cups, and for a control group of all other MoM 
THRs, were higher in primary hips implanted from 2007 onwards compared with those 
implanted pre-2007. Hips implanted from 2007 onwards were distinguished from earlier 
implantations as 2007 represented the first complete calendar year following the postulated 
changes in the Pinnacle clearance values.12 
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Patients and Methods 
 
Study design and data source 
We performed a retrospective observational cohort study using the NJR, which has recorded 
all hip replacements performed at hospitals in England and Wales since April 2003.11 Unique 
patient identifiers allow linkage of primary procedures to any subsequent revisions where 
components were removed or exchanged. The NJR obtains data on time to death following 
arthroplasty from the Personal Demographics Service. 
 
Participants, selection criteria, and implants 
Anonymised patient data were extracted from the NJR up to and including 31st December 
2015.11 The dataset included all primary 36 mm MoM THRs with an uncemented Pinnacle 
acetabular component implanted with either a Corail (12/14 taper) or SROM (11/13 taper) 
stem (all components manufactured by DePuy). The last implantation was in August 2012. 
The Corail and SROM stems represented the two most commonly used femoral stems with 
Pinnacles, and were selected as these designs were studied previously.12, 17 The final cohort 
for analysis included 11,826 primary 36mm Pinnacles. Both femoral components were 
uncemented titanium alloy stems, and were implanted with an Ultamet cobalt-chrome alloy 
liner, and either an Ultamet (SROM) or Articul/eze (Corail) cobalt-chrome alloy femoral 
head (all manufactured by DePuy). Further information about these components has been 
described.12, 15, 19 
 
A control group of all other primary MoM THRs (>36 mm) implanted between 2003 and 
2012 was extracted from the NJR (n=14,934). This group included all manufacturer designs 
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apart from ASR MoM THRs (DePuy), and MoM THRs with Pinnacle cups. The control 
group therefore included a variety of manufacturer designs and femoral head sizes. 
 
Exposures and outcomes 
The exposure (intervention) of interest was the year of primary hip implantation, which was 
grouped as described. For all procedures the NJR collects data on patient demographics and 
the surgical procedure (age, gender, body mass index (BMI), American Society of 
Anesthesiologists (ASA) grade, indication, surgeon grade, and components implanted), 
which were adjusted for in our analysis. 
 
The study outcome was all-cause revision surgery (removal or exchange of any primary 
arthroplasty component). Surgeons can record one or multiple indications when performing 
revisions, including infection, periprosthetic fracture, aseptic loosening, 
dislocation/subluxation, adverse soft tissue reaction to particulate debris (latter available 
since June 2008),11 lysis, implant malalignment, implant wear, implant fracture, head/socket 
mismatch, liner dissociation, pain, and other.  
 
Statistical analysis  
All analyses were performed using Stata Version 13.1 (Lakeway Drive, Texas, USA), with a 
5% level of significance and 95% confidence intervals (CI). Cumulative all-cause revision 
rates following primary Pinnacle arthroplasty were estimated using the Kaplan-Meier 
method. Hips not undergoing revision were censored on the study end date (31st December 
2015), or at the time of death (if earlier). Revision rates were determined for the whole 
cohort, and also for a follow-up controlled cohort in Pinnacles only (referred to subsequently 
as the 5-year cohort). The 5-year cohort included all patients with the potential for at least 5-
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years follow-up (hence by definition had their primary before 2011) with revision outcomes 
censored at 5-years from the date of primary operation in patients not undergoing revision or 
death within 5-years (Table 1). 
 
Cox proportional hazards models (univariable and multivariable) were used to assess the 
effect of year of primary hip implantation on time to all-cause revision surgery in both the 
whole cohort (for Pinnacles) and the 5-year cohort (for both Pinnacles and other MoM 
THRs). Proportional hazards assumptions were assessed using Schoenfeld’s residuals and 
satisfied. Multivariable models were adjusted for age, gender, BMI, ASA grade, indication, 
surgeon grade, femoral stem design, and bilateral MoM THRs. 
 
For the 5-year cohort (for both Pinnacles and other MoM THRs), 5-year all-cause revision 
rates were calculated for each calendar year of implantation. The 5-year revision rate was 
calculated by dividing the total number of all-cause revisions by the total of the individual 
implant-years at risk in the 5-year cohort. The 5-year revision rate was expressed as the 
number of all-cause hip revisions per 1000 implant-years at risk. 
 
Interrupted time-series analysis (longitudinal quasi-experimental design)20 was used to assess 
the trends in six-monthly 5-year revision rates before 2007 and from 2007 onwards. This was 
performed for Pinnacles and other MoM THRs separately. Analyses were based on 6 pre-
intervention data points (January 2004 to July 2006), and 8 post-intervention data points 
(January 2007 to July 2010). Segmented linear regression models were used to estimate 
changes in 5-year revision rates immediately after 2007. Controlling for baseline level and 
trend, the models estimate changes in levels and trends of rates after 2007. The regression 
model includes terms to estimate the pre-existing level for each rate in the first 6-months of 
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the observation period (intercept), trend in the rate before the change in 2007, change in level 
of the rate after 2007, and change in trend after 2007. Regression diagnostics confirmed the 
underlying model assumptions, and that there was no evidence of serial autocorrelation 
(Durban-Watson test) and seasonality.21 
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Results 
 
Whole Pinnacle cohort (11,826 hips) 
All-cause revision surgery was performed in 1,190 (10.1%) hips at a mean time of 4.6 years 
(range 0.003-11.1 years) from arthroplasty. The commonest revision indication was adverse 
soft tissue reaction to particulate debris (48.6%) (Table 2). The mean follow-up time in 8,952 
surviving non-revised hips was 7.7 years (3.4-12.6 years), with a mean time to death in 1,684 
non-revised hips of 4.5 years (0.003-12.0 years). The cumulative all-cause 10-year revision 
rate was 15.2% (CI=14.2%-16.4%; 678 hips at risk at 10-years). 
 
The association of the year of primary Pinnacle implantation on outcome was non-linear. 
This had the potential to violate the assumptions of the statistical analyses performed, 
including the requirement for a linear trend in the pre-2007 time period to undertake 
interrupted time series analysis. Specifically the few hips implanted in 2003 (n=48) had high 
revision rates (23.8% at 10-years), which were very different to the many other hips 
implanted before 2007. It was therefore necessary to group Pinnacle hips implanted in 2003 
separately, to satisfy the model assumption of linearity. Pinnacles implanted in 2007-2012 
had higher revision rates compared with those implanted in 2004-2006 (Hazard Ratio 
(HR)=1.21; CI=1.05-1.40; p=0.008) (Figure 1). 
 
5-year Pinnacle cohort (10,776 hips) 
In the 5-year cohort, 627 (5.8%) hips were revised for any indication at a mean time of 2.7 
years (range 0.003-4.99 years) from arthroplasty (Table 1). The commonest revision 
indication was adverse soft tissue reaction to particulate debris (31.6%) (Table 2). The 5-year 
all-cause revision rate was 5.8% (CI=5.4%-6.3%). 
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5-year Pinnacle cohort: Cox regression analysis 
Univariable analysis demonstrated that compared with primary Pinnacles implanted in 2004-
2006, both hips implanted in 2007-2012 (HR=2.01; CI=1.57-2.57; p<0.001) and in 2003 
(HR=4.57; CI=1.99-10.5; p<0.001) had significantly higher revision rates. Adjusting for all 
covariates (excluding BMI; n=10,776) in a multivariable model produced similar results: 
2007-2012 (HR=2.22; CI=1.73-2.85; p<0.001) and 2003 (HR=2.44; CI=1.03-5.77; p=0.042). 
Adjusting for all co-variates (including BMI; n=4,446) in a multivariable model also 
produced similar results: 2007-2012 (HR=2.23; CI=1.42-3.51; p=0.001), with no hips in 2003 
included due to missing BMI data. The inclusion of BMI in the model therefore did not 
change the findings. 
 
As a sensitivity analysis, the multivariable model was repeated with the 1,345 Pinnacles 
implanted in 2006 excluded. This demonstrated that compared with primary Pinnacles 
implanted in 2004-2005, hips implanted in 2007-2012 continued to have significantly higher 
revision rates (HR=2.05; CI=1.46-2.87; p<0.001). 
 
5-year Pinnacle cohort: Interrupted time-series analysis 
For primary Pinnacles implanted between 2004 and 2010, the 5-year revision rate ranged 
from 5.74 (CI=2.39-13.8) all-cause hip revisions per 1000 implant-years at risk in 2004 to 
14.6 (CI=12.6-17.0) all-cause hip revisions per 1000 implant-years at risk in 2009. 
 
The interrupted time-series analysis assessed trends in the 5-year revision rate for primary 
Pinnacles implanted before 2007 and from 2007 onwards (Figure 2). For primary Pinnacles 
implanted before 2007 there was a non-significant downward trend in the 5-year revision rate 
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over time (p=0.773). Immediately after 2007, the 5-year revision rate significantly increased 
by 5.20 (CI=0.52-9.89; p=0.033) compared with before 2007. For primary Pinnacles 
implanted from 2007 onwards there was a non-significant increasing trend in the 5-year 
revision rate (p=0.450), which demonstrated that the increase in revision rates occurring 
immediately after 2007 persisted in subsequent years.  
 
5-year control group of all other MoM THRs (13,817 hips) 
The 5-year control group included 13,817 other MoM THRs (Table 1), with 877 (6.3%) all-
cause revisions at a mean time of 3.9 years (range 0.003-5.0 years) from arthroplasty.  
 
Univariable Cox regression analysis demonstrated that compared with primary MoM THRs 
implanted in 2004-2006, primary MoM THRs implanted in 2007-2012 (HR=1.77; CI=1.49-
2.10; p<0.001) had significantly higher revision rates. Adjusting for all covariates (excluding 
BMI; n=13,817) in a multivariable model produced similar results: 2007-2012 (HR=1.79; 
CI=1.51-2.13; p<0.001). Adjusting for all co-variates (including BMI; n=4,377) in a 
multivariable model produced similar results: 2007-2012 (HR=1.91; CI=1.23-2.98; p=0.004). 
The inclusion of BMI in the model therefore did not change the findings. 
 
For primary MoM THRs implanted between 2004 and 2010, the 5-year revision rate ranged 
from 7.42 (CI=4.79-11.5) in 2005 to 17.8 (CI=15.1-21.0) in 2008. Interrupted time-series 
analysis demonstrated that primary MoM THRs implanted immediately before 2007 had a 
non-significant downward trend in the 5-year revision rate over time (p=0.251) (Figure 2). 
Immediately after 2007, the 5-year revision rate significantly increased by 6.13 (CI=1.42-
10.83; p=0.016) compared with before 2007. For primary MoM THRs implanted from 2007 
onwards there was a non-significant increasing trend in the 5-year revision rate (p=0.241), 
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which demonstrated that the increase in revision rates occurring immediately after 2007 had 
persisted in subsequent years. 
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Discussion 
Data from the world’s largest arthroplasty registry demonstrated that all primary MoM THRs 
implanted from 2007 onwards had significantly higher five-year revision rates compared with 
those implanted before 2007. The finding was not specific to Pinnacle implants, and therefore 
does not currently support recent observations.12, 17 
 
When assessing the effect of a time dependent variable (year of implantation) on revision 
rates it is necessary to control for the varying lengths of patient follow-up. In the 5-year 
cohort with a controlled follow-up time Pinnacles implanted from 2007-2012 had double the 
risk of revision compared with those implanted in 2004-2006, even when adjustment was 
made for potential confounders. The interrupted time-series analysis clearly demonstrated 
that immediately after 2007 there was a significant increase in revision rates for Pinnacles, 
with the 5-year revision rate almost doubling compared with Pinnacles implanted before 
2007 (Figure 2). For primaries implanted from 2007 onwards there were no significant 
changes in subsequent revision rates, therefore the increase in revision rate occurring 
immediately after 2007 was sustained in future years. In isolation these observations support 
those from two recent studies.12, 17 However analysis of a large control group of MoM THRs 
with non-Pinnacle cups was important to put the findings into context. This demonstrated that 
the findings for other MoM THRs implanted from 2007 onwards closely paralleled those in 
Pinnacles. 
 
The universal increase in revision rates for all primary MoM THR designs implanted from 
2007 onwards in a large registry cohort with controlled follow-up time is likely to be 
explained by more intensive patient surveillance in recent years as well as the progressive 
lowering of the threshold for performing revision. High revision rates for MoM THRs were 
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first identified in ASR implants leading to a voluntary manufacturer recall and an alert from 
the Medical and Healthcare products Regulatory Agency (MHRA) in 2010.1, 22 High revision 
rates were subsequently observed in other MoM THR designs.2-4, 11 This led to another 
MHRA alert being issued in 2012, recommending that all patients with 36 mm or greater 
MoM THRs required a minimum of annual clinical surveillance, regardless of symptoms.8 
Some centres had routinely started investigating MoM THR patients earlier than 201212, 14 
because of problems reported with hip resurfacings.23, 24 Furthermore the poor short-term 
outcomes following MoM hip arthroplasty revision surgery performed for adverse reactions 
to metal debris (ARMD)25, 26 led surgeons and worldwide regulatory authorities to widely 
recommend performing early revisions.8-10, 25, 27 Surgeons subsequently adopted a lower 
threshold for performing revision surgery for ARMD in MoM hip arthroplasty patients, with 
evidence that this strategy can improve outcomes.27, 28 It is important to recognise that as our 
study used a 5 year follow-up period from primary surgery, only the revision rates in the 
2007 onwards group would have significantly been influenced by the increased surveillance 
and lowering of the revision threshold which largely occurred from 2012 onwards. It is also 
worth acknowledging that although the 2007 time point was of a-priori interest here, the data 
presented does also demonstrate a general trend of increasing revision rates with time for all 
MoM THRs recorded in the NJR (Figure 3). Regular patient surveillance, and lowering the 
revision threshold over time are again likely responsible for this. 
 
A recent systematic review demonstrated that more intensive surveillance protocols (blood 
metal ions and cross-sectional imaging) were associated with the highest prevalence of 
ARMD revision surgery.29 Given that most MoM THR patients will have undergone such 
intensive surveillance since 2012,8 it would be expected that all primary MoM THRs 
implanted from 2007 onwards would have significantly higher 5-year revision rates 
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compared with those implanted before 2007 that were not universally subjected to this 
follow-up. In addition to surveillance bias, the lowering of the threshold for performing 
revision has also been implicated in the increasing ARMD failure rates observed following 
MoM hip arthroplasty.17, 30 A report on 1,429 hip resurfacings demonstrated that those 
implanted from 2007 onwards had a 2.4 times increased risk of ARMD revision compared 
with hip resurfacings implanted before 2007.30 The present NJR findings in all MoM THRs 
supports recent observations in hip resurfacings. 
 
Based on the current findings no changes to surveillance protocols for MoM THR patients 
are presently recommended.8-10 However registries can underreport revisions,31, 32 and they 
do not contain data on explant analyses. Hence if there truly was a widespread change in the 
Pinnacle manufacturing process that has the potential to influence revision rates, as suggested 
by implant retrievals,12 then it may take time for this to be detected within the registry. Indeed 
it took some time for registries to detect problems with recalled ASR MoM hip 
arthroplasties.8, 9, 11 Furthermore one study reported that the higher failure rates with more 
recent primary Pinnacles only became apparent between 4 and 8 years following 
arthroplasty.17 This may not have been apparent in the present analysis because it was based 
on a cohort with 5-year follow-up. Therefore the NJR analysis should be repeated in future 
years to establish whether or not revision rates for Pinnacles implanted from 2007 onwards 
have substantially increased relative to other MoM THRs. 
 
Study strengths include using a large unselected population (approximately 7% of all 
Pinnacles implanted worldwide),12 which reduces the likelihood of sampling bias and 
increases generalisability of our findings. The large cohort ensures adequate statistical power 
when assessing revision rates in relation to year of primary MoM THR implantation. The 
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NJR uses linked data to capture revisions performed at different institutions, with almost 
complete compliance now reported.11 This study was strengthened by having a large control 
group. Without this comparator group the findings would have been incorrectly interpreted. 
 
Study limitations include using observational registry data, which means we cannot infer 
causality. However this work was undertaken specifically to assess whether the findings 
regarding year of implantation and failure rates were reproducible in a large population. 
Registries can also underreport arthroplasty failures, with a recent NJR implant retrieval 
validation study reporting that 23% of revisions performed were not on the NJR.31, 32 
Therefore our revision rates may be underestimated. Femoral component design was a 
potential confounder given that stem design usage with Pinnacles has varied over time 
(Appendix), and that the SROM has a higher revision rate compared with the Corail.11 
However femoral design was controlled for in the multivariable models, and did not change 
the findings. In line with worldwide usage,2, 3, 11 small numbers of Pinnacles were implanted 
in 2003 and from 2011 onwards, therefore revision rates for these years could not be 
meaningfully assessed. Although revision rates have been reported per year of implantation 
this does not necessarily reflect year of manufacture. This may be most relevant in centres 
implanting smaller volumes.  
 
Interrupted time-series analysis generally requires at least 8 pre-intervention and post-
intervention data points,33 and at least 100 observations at each time point,34 to achieve an 
acceptable level of variability of the estimate at each time point. Whilst the number of 
observations available at each time point was high, we were limited by the number of pre-
intervention time points. As it was not known exactly when potential changes in Pinnacle 
implant clearance occurred in 2006 it is possible that some implants with new clearance 
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values were included in the pre-2007 group. This cut-off was chosen to ensure further power 
was not lost with the pre-intervention aspect of the time-series analysis. However it is clear 
that excluding the 2006 data points would not have changed the findings (Figures 2 and 3), 
which was confirmed in a multivariable model with 2006 Pinnacle implantations excluded. A 
fixed follow-up interval of five-years was chosen to reduce the bias when comparing revision 
rates between the Pinnacle and control groups, with similar methods being used previously.17 
However it is recognised that the revision rates by year of primary implantation in both the 
Kaplan Meier and interrupted time-series analyses will have been influenced by the external 
time dependent confounder of increased surveillance and lowering of the revision threshold 
in more recent years. This must be considered when interpreting our findings. It is also 
acknowledged that the control group was heterogeneous (included a variety of MoM THR 
implant designs and femoral head sizes) compared with the Pinnacle group. This was 
necessary to ensure adequate numbers for powering the study given the large Pinnacle group. 
However this is mitigated by all MoM THRs with 36 mm or larger femoral head sizes being 
treated differently from 2012 onwards, with increased surveillance and reduced thresholds for 
performing revision surgery. Finally, there is a potential for residual confounding in the 
analysis. 
 
Conclusions 
Data from the world’s largest arthroplasty registry has demonstrated that five-year revision 
rates were significantly increased in all primary MoM THRs implanted from 2007 onwards 
compared with those implanted before 2007. The finding was not specific to Pinnacle 
implants, and therefore does not support recent concerns regarding potential changes in the 
Pinnacle device manufacturing process and higher revision rates in more recent years.12, 1717 
The observations in NJR data regarding the change in revision rates for all MoM THRs with 
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time may be explained by more intensive patient surveillance and the progressive lowering of 
the threshold for performing revision surgery. 
 
Take home message  
Five-year revision rates were significantly increased in all primary MoM THRs implanted 
from 2007 onwards, and not just in Pinnacles. These observations may be explained by more 
intensive patient surveillance and the progressive lowering of the threshold for performing 
revision over time. 
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Table 1 Demographics for patients receiving primary metal-on-metal total hip replacements 
Covariate  Pinnacle 
5-year cohort 
(10,776 hips) 
Other MoM THR 
5-year cohort 
 (13,817 hips) 
Gender Female /  
Male 
 5,703 (52.9%) / 
5,073 (47.1%) 
6,640 (48.1%) /  
7,177 (51.9%) 
Age at primary Mean (range) in years 65.4 (17 to 97) 60.9 (30 to 92) 
Body mass index * Mean (range) in kg/m2 28.8 (16 to 60) 29.0 (16 to 60) 
ASA grade 1 
2 
3 or above 
1,953 (18.1%) 
7,324 (68.0%) 
1,499 (13.9%) 
4,503 (32.6%) 
8,233 (59.6%) 
1,081 (7.8%) 
Hip laterality Unilateral / Bilateral 
MoM THR 
9,076 (84.2%) / 
1,700 (15.8%) 
*** 
Year of primary 2003 
2004 
2005 
2006 
2007 
2008 
2009 
2010 
2011 
2012 
43 (0.4%) 
178 (1.7%) 
687 (6.4%) 
1,345 (12.5%) 
2,330 (21.6%) 
2,826 (26.2%) 
2,403 (22.3%) 
961 (8.9%) 
** 
** 
227 (1.6%) 
574 (4.2%) 
1,276 (9.2%) 
1,975 (14.3%) 
3,016 (21.8%) 
3,443 (24.9%) 
2,191 (15.9%) 
1,094 (7.9%) 
** 
** 
 
Year of primary 
(grouped) 
2003 
2004 to 2006 
2007 to 2012 
43 (0.4%) 
2,210 (20.5%) 
8,523 (79.1%) 
227 (1.6%) 
3,825 (27.7%) 
9,765 (70.7%) 
Hip diagnosis Primary osteoarthritis 
/ Other 
10,222 (94.9%) /  
554 (5.1%) 
12,679 (91.8%) / 
1,138 (8.2%) 
Surgeon grade Consultant /  
Other 
9,019 (83.7%) / 
1,757 (16.3%) 
12,225 (88.5%) / 
1,592 (11.5%) 
Femoral stem  Corail /  
SROM 
10,067 (93.4%) /  
709 (6.6%) 
**** 
 
 
ASA = American Society of Anesthesiologists; MoM THR = metal-on-metal total hip 
replacement 
* Body mass index data was available for 4,446 hips (41.3%) in the Pinnacle cohort and 
4,377 hips (31.7%) in the other MoM THR cohort. 
** Data suppressed due to small count within the cell. The actual number was between 1 and 
5. 
*** Unable to determine hip laterality for this cohort given the dataset available. 
**** Multiple implant combinations used so this information was not provided. 
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Table 2 Indications for all-cause revision surgery following 36mm metal-on-metal total hip 
replacement with Pinnacle cups 
Indication for revision 
surgery 
Number of revised hips with 
indication in whole cohort 
Number of revised hips with 
indication in 5-year cohort 
Adverse soft tissue 
reaction to particulate 
debris * 
578 (48.6%) 198 (31.6%) 
Pain 252 (21.2%) 153 (24.4%) 
Aseptic loosening 202 (17.0%) 118 (18.8%) 
Other 178 (15.0%) 122 (19.5%) 
Dislocation / subluxation 96 (8.1%) 77 (12.3%) 
Infection 93 (7.8%) 61 (9.7%) 
Implant malalignment 76 (6.4%) 47 (7.5%) 
Periprosthetic fracture 56 (4.7%) 32 (5.1%) 
Lysis 46 (3.9%) 25 (4.0%) 
Implant wear 44 (3.7%) 24 (3.8%) 
Implant fracture 14 (1.2%) 9 (1.4%) 
Head / Socket mismatch 8 (0.7%) ** 
 
One or more indications may be selected for each hip undergoing revision. 
A number of the revision indications (aseptic loosening; implant malalignment; periprosthetic 
fracture; lysis; implant fracture) can include a problem on either the femoral side or the 
acetabular side or both sides. 
* Adverse soft tissue reaction to particulate debris was only introduced as a revision 
indication for surgeons to select from June 2008 onwards. 
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** Data suppressed due to small count within the cell. The actual number was between 1 and 
5. 
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Appendix Table Femoral component design implantation over time for the whole Pinnacle 
cohort (11,826 hips) 
Year of implantation Corail stem 
 
SROM stem 
 
2003 
 
2 (4.2%) 
 
46 (95.8%) 
 
2004 
 
91 (48.2%) 
 
98 (51.8%) 
 
2005 
 
649 (86.9%) 
 
98 (13.1%) 
 
2006 
 
1,405 (95.6%) 
 
64 (4.4%) 
 
2007 
 
2,404 (94.8%) 
 
131 (5.2%) 
 
2008 
 
2,950 (95.9%) 
 
126 (4.1%) 
 
2009 
 
2,454 (94.2%) 
 
150 (5.8%) 
 
2010 
 
1,002 (94.8%) 
 
55 (5.2%) 
 
2011 
 
91 (100%) 
 
0 (0%) 
 
2012 
 
10 (100%) 
 
0 (0%) 
 
Percentages are for the number of specified femoral component designs implanted in each 
calendar year. 
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Figure legends 
 
Figure 1 Cumulative all-cause revision rates following metal-on-metal total hip replacement 
with 36mm Pinnacle cups at up to 7-years following primary implantation for the whole 
cohort (11,826 hips) 
 
95% confidence intervals have been omitted for clarity. The number of hips at risk at 7-years 
for each year primary implantation group were: 2003 = 34 hips; 2004-2006 =1,955 hips; 
2007-2012 = 4,414 hips. 
 
Figure 2 Trends in the 5-year all-cause revision rates at six-month intervals for 10,730 metal-
on-metal total hip replacements with Pinnacle cups, and a control group of 13,817 other 
metal-on-metal total hip replacement designs. 
 
The 5-year revision rate has been expressed as the number of all-cause hip revisions per 1000 
implant-years at risk. Trends in 5-year revision rates were analysed using segmented linear 
regression. The year 2007 was chosen as the transition point given that this represents the 
first complete calendar year since potential changes in the Pinnacle manufacturing process 
were made. 
 
Figure 3 Trends in the 5-year all-cause revision rates for all metal-on-metal total hip 
replacements with year of primary implantation. 
 
The 5-year revision rate has been expressed as the number of all-cause hip revisions per 1000 
implant-years at risk. 
